Page last updated: 2024-09-23

lupulon

Description

lupulon: antibiotic from hops; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

lupulone : A beta-bitter acid in which the acyl group is specified as 3-methylbutanoyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

beta-bitter acid : An alicyclic ketone obtained by prenylation at positions 4, 6 and 6 of any 2-acylphloroglucinol. beta-bitter acids are well known for their contribution to the bitter taste of beer. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID68051
CHEMBL ID480267
CHEBI ID6574
SCHEMBL ID819253
SCHEMBL ID2431439
MeSH IDM0052026

Synonyms (39)

Synonym
3,5-dihydroxy-2,6,6-tris(3-methylbuten-2-yl)-4-(3-methyl-1-oxobutyl)cyclohexa-2,4-dien-1-one
lupulon
b'' -acid
einecs 207-405-3
2,4-cyclohexadien-1-one, 3,5-dihydroxy-4-isovaleryl-2,6,6-tris(3-methyl-2-butenyl)-
beta-bitter acid
3,5-dihydroxy-2,6,6-tris(3-methyl-2-butenyl)-4-(3-methyl-1-oxobutyl)-2,4-cyclohexadien-1-one
beta-lupulic acid
lupulone
468-28-0
3,5-dihydroxy-2-(3-methylbutanoyl)-4,6,6-tris(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one
3,5-dihydroxy-2-(3-methylbutanoyl)-4,6,6-tris(3-methylbut-2-en-1-yl)cyclohexa-2,4-dien-1-one
FT-0650864
chebi:6574 ,
CHEMBL480267
b7425usg94 ,
unii-b7425usg94
2,4-cyclohexadien-1-one,3,5-dihydroxy-2,6,6-tris(3-methyl-2-buten-1-yl)-4-(3-methyl-1-oxobutyl)-
AKOS015896772
lupulon [mi]
.beta.-bitter acid
.beta.-lupulic acid
SCHEMBL819253
hop beta-acid
SCHEMBL2431439
3,5-dihydroxy-4-(3-methylbutanoyl)-2,6,6-tris(3-methyl-2-butenyl)-2,4-cyclohexadien-1-one #
2,4-cyclohexadien-1-one, 3,5-dihydroxy-2,6,6-tris(3-methyl-2-butenyl)-4-(3-methyl-1-oxobutyl)-
3,5-dihydroxy-2,6,6-tris(3-methyl-2-buten-1-yl)-4-(3-methyl-1-oxobutyl)-2,4-cyclohexadien-1-one
lupolon
DTXSID00875553
Q55939056
3,5-dihydroxy-2,6,6-tris(3-methylbut-2-enyl)-4-(3-methyl-1-oxobutyl)cyclohexa-2,4-dien-1-one
3,5-dihydroxy-2,6,6-tris(3-methylbut-2-enyl)-4-(3-methylbutanoyl)cyclohexa-2,4-dienone
Q27107249
HY-124923
CS-0089577
gtpl12445
AKOS040744749
PD118550

Research Excerpts

Overview

ExcerptReference
"Lupulone is a compound extracted from Hops (Hurnulus lupulus), which exhibits a good antimicrobial activity against M."( Guo, N; Liang, J; Meng, R; Shi, Q; Tang, X; Wei, J; Yu, L; Yuan, P, 2014)

Treatment

ExcerptReference
"Lupulone treatment enhanced the expression of the anti-apoptotic Mcl-1 protein by 60% favoring the preservation of mitochondrial integrity."( Bousserouel, S; Gossé, F; Lamy, V; Lobstein, A; Minker, C; Raul, F, 2011)

Roles (4)

RoleDescription
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
angiogenesis inhibitorAn agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
beta-bitter acidAn alicyclic ketone obtained by prenylation at positions 4, 6 and 6 of any 2-acylphloroglucinol. beta-bitter acids are well known for their contribution to the bitter taste of beer.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID376758Cytotoxicity against mouse RAW264.7 cells after 16 hrs by MTT assay2005Journal of natural products, Jan, Volume: 68, Issue:1
Prenylflavonoids and phloroglucinol derivatives from hops (Humulus lupulus).
AID376752Inhibition of LPS/IFN-gamma-induced NO production in mouse RAW264.7 cells after 16 hrs2005Journal of natural products, Jan, Volume: 68, Issue:1
Prenylflavonoids and phloroglucinol derivatives from hops (Humulus lupulus).
AID600520Antioxidant activity assessed as inhibition of lipid peroxidation2009Journal of natural products, Jun, Volume: 72, Issue:6
Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds.
AID600519Antioxidant activity assessed as DPPH radical scavenging activity2009Journal of natural products, Jun, Volume: 72, Issue:6
Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds.
AID376757Inhibition of LPS/IFN-gamma-induced NO production in mouse RAW264.7 cells at non cytotoxic concentration after 16 hrs2005Journal of natural products, Jan, Volume: 68, Issue:1
Prenylflavonoids and phloroglucinol derivatives from hops (Humulus lupulus).
AID600510Antiangiogenic activity in mouse at 0.01%, po for 21 days2009Journal of natural products, Jun, Volume: 72, Issue:6
Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (25.49)18.7374
1990's1 (1.96)18.2507
2000's10 (19.61)29.6817
2010's24 (47.06)24.3611
2020's3 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Bioavailability (2)

ArticleYear
Antibacterial hop extracts encapsulated in nanochitosan matrices.
International journal of biological macromolecules, Volume: 120, Issue: Pt A
2018
Beer and beer compounds: physiological effects on skin health.
Journal of the European Academy of Dermatology and Venereology : JEADV, Volume: 28, Issue: 2
2014
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (1)

ArticleYear
Antimicrobial activity of lupulone against Clostridium perfringens in the chicken intestinal tract jejunum and caecum.
The Journal of antimicrobial chemotherapy, Volume: 61, Issue: 4
2008
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (1)

ArticleYear
In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris.
Phytomedicine : international journal of phytotherapy and phytopharmacology, Volume: 16, Issue: 4
2009
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]